Allen B Reitz

Lansdale, PA, United States of America

Allen B Reitz

This inventor holds 101 USPTO granted patents and 25 published patent applications, plus 4 CIPO patents and 20 EPO patents, primarily in Prodrug Development (CPC class A61K45-06). Top assignees: Janssen Pharmaceutica Nv, Ortho-Mcneil Pharmaceutical Corp., Biohaven Therapeutics Ltd.. Active years: 1988-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Allen B Reitz. Retrieved from https://idiyas.com/inventor/allen-b-reitz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 101 

% Patents Active = 81.2

 

 

Average Co-Inventor Count = 4.1

ph-index = 12

Forward Citations = 396(Granted Patents)

Forward Citations (Not Self Cited) = 305(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • North Wales, PA (US) (1988)
  • Landsdale, PA (US) (2021)
  • Lansdale, PA (US) (1994 - 2024)

Company Filing History:

goldMedal22 out of 2,103 
 
Janssen Pharmaceutica Nv
 patents
silverMedal22 out of 363 
 
Ortho-Mcneil Pharmaceutical Corp.
 patents
bronzeMedal12 out of 33 
 
Biohaven Therapeutics Ltd.
 patents
4. 8 out of 8 
 
Biohaven Pharmaceutical Holding Company Limited
 patents
5. 7 out of 189 
 
Mcneil Ab
 patents
6. 7 out of 247 
 
The Wistar Institute
 patents
7. 4 out of 1,502 
 
Rutgers, The State University of New Jersey
 patents
8. 4 out of 1,209 
 
Scripps Research Institute
 patents
9. 3 out of 10 
 
Oligomerix, Inc.
 patents
10. 3 out of 377 
 
Ortho Pharmaceutical Corporation
 patents
11. 2 out of 179 
 
Musc Foundation for Research Development
 patents
12. 2 out of 2,668 
 
University of Pennsylvania
 patents
13. 1 out of 1 
 
Advanced Neural Dynamics, Inc.
 patent
14. 1 out of 1 
 
Fox Chase Chemical Diversity Center, Inc.
 patent
15. 1 out of 271 
 
Johnson & Johnson Consumer Companies, Inc.
 patents
16. 1 out of 3 
 
Kleo Pharmaceuticals, Inc.
 patents
17. 1 out of 1 
 
Leukogene Therapeutics Incorporated
 patent
18. 1 out of 1 
 
Lukogene Therapeutics Incorporated
 patent
19. 1 out of 1 
 
Ncneilab, Inc.
 patent
20. 1 out of 5 
 
Pfizer Ireland Pharmaceuticals
 patents
21. 1 out of 1,376 
 
Yale University
 patents
22. 4 out of 834,708 
Other
 patents
where one patent can have more than one assignee

Years Active: 1988-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Prodrugs
Riluzole
EBNA1 Inhibitors
Tau Oligomers
CGRP Antagonists
Indole Analogs
Cancer Treatment
Antiviral Compounds
Bipolar Disorder
Epilepsy Treatment
Pain Management
Sulfamide Derivatives
101 patents (USPTO):Explore Patents

Title: Allen B Reitz: Pioneering Innovator in the Field of Pharmaceuticals

Introduction:

In the domain of pharmaceuticals, exceptional individuals like Allen B Reitz have made groundbreaking contributions by developing innovative compounds and inventions to combat diseases. With an impressive portfolio of patents and a notable career history, Allen B Reitz has earned recognition as a pioneering innovator. This article explores some of his latest patents, career highlights, and collaborations, shedding light on his remarkable achievements.

Latest Patents:

Allen B Reitz's latest patents demonstrate his ingenuity and dedication to finding solutions for challenging medical conditions. One of his recent inventions is centered around indene derivatives and their potential use in the treatment of cancer. These compounds, formulated based on formula (I), exhibit promising properties for combating this deadly disease.

In addition, Reitz has invented novel quinazolinones that inhibit the formation of tau oligomers, which play a crucial role in neurodegenerative diseases. These compounds offer potential therapeutic benefits for the treatment of neurodegenerative conditions, representing a significant breakthrough in the field. Reitz's patents also cover the preparation of these compounds, their intermediates, and pharmaceutical compositions comprising them.

Career Highlights:

Throughout his career, Allen B Reitz has left an indelible mark within the pharmaceutical industry. He has worked diligently for renowned companies, including Janssen Pharmaceutica N.V. and Ortho-McNeil Pharmaceutical Corp., where he contributed significantly to research and development efforts. Reitz's expertise and dedication have propelled him forward, resulting in an impressive portfolio of 83 patents.

Collaborations:

Within the collaborative realm, Allen B Reitz has had the opportunity to work with accomplished professionals who share his passion for scientific exploration. Notable colleagues such as Garry Robert Smith and Tina Morgan Ross have joined forces with Reitz to strive for advancements in pharmaceutical research. Collaborations such as these have fostered a fertile environment for innovative ideas and expedited the development of novel inventions.

Conclusion:

Allen B Reitz stands as an exemplary figure in the field of pharmaceuticals, highlighting the power of innovation and ingenuity in battling diseases. His latest patents, focused on developing effective treatments for cancer and neurodegenerative conditions, portray his commitment to improving the lives of patients worldwide. With an extensive career history and influential collaborations, Reitz's contributions have made a lasting impact on the pharmaceutical industry. As we look ahead to the future, we eagerly anticipate the next wave of innovations from visionaries like Allen B Reitz.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…